Author: Aliya Jayed

  • Reimagining a Fit-for-Purpose Health Politics and Diplomacy Agenda for a Changing Global Health Order

    Reimagining a Fit-for-Purpose Health Politics and Diplomacy Agenda for a Changing Global Health Order

    Health Diplomacy is the art and science by which governments, the private sector, civil society, and individuals navigate political processes to improve health outcomes. Global health diplomacy is far more than health negotiations between countries. It is the political and diplomatic process through which governments, international organisations, researchers, civil society, and the private sector build consensus, manage competing interests, and forge partnerships to tackle shared health challenges. At its core, global health diplomacy recognises that improving health in the twenty-first century requires not only scientific evidence but also political will, international cooperation, and skilled negotiation across sectors and borders.

    Global health is entering a new political era. The assumptions that have shaped international health cooperation over the past three decades are increasingly being challenged by geopolitical competition, shrinking development assistance, pandemics, climate change, armed conflict, migration, artificial intelligence, and declining trust in multilateral institutions. These forces are not simply changing the context within which global health operates; they are fundamentally reshaping how health priorities are negotiated, financed, implemented, and governed.

    An uncomfortable question deserves greater attention: is the health diplomacy paradigm we have inherited still fit for purpose? What are we – should be done about this?

    Over the past two decades, health diplomacy has become firmly embedded within global health governance. It has strengthened international cooperation, facilitated global agreements, mobilised resources, and elevated health within foreign policy. These achievements cannot be underestimated.

    Yet many of today’s greatest health challenges are proving resistant to diplomacy alone.

    Pandemic preparedness, domestic health financing, local manufacturing, health workforce migration, antimicrobial resistance, climate resilience, and equitable access to innovation are as much political challenges as they are technical or diplomatic ones.

    Perhaps the time has come to move beyond thinking exclusively about health diplomacy and begin embracing a broader and more integrated discipline of health politics and diplomacy.

    The distinction is more than academic.

    Health diplomacy provides the mechanisms through which countries negotiate, build partnerships, broker consensus, and pursue collective action. Health politics determines whose priorities prevail, how power is exercised, where resources are allocated, and whether agreements ultimately translate into implementation. Diplomacy therefore operates within political realities rather than above them.

    Much like law and ethics occupy distinct but complementary roles in governance, health politics and health diplomacy should similarly be understood as mutually reinforcing rather than interchangeable disciplines. Ethical approval may not itself be legally binding, yet it remains indispensable for legal legitimacy and accountability. Likewise, diplomacy creates opportunities for cooperation, while politics determines whether those opportunities can be realised.

    The political determinants of health are now widely recognised. Yet political capability remains remarkably underdeveloped across the global health workforce. Public health professionals are extensively trained in epidemiology, biostatistics, health systems, implementation research, and programme management. Comparatively little attention is devoted to political economy, negotiation, stakeholder influence, coalition building, governance, institutional incentives, or strategic communication—despite these often determining whether evidence is translated into policy.

    As Dr. John Nkengasong has argued, meaningful health impact requires both good science and good politics. Similarly, Professor Peter Piot (We need more good people in active politics) recently challenged global health professionals to engage more actively with political leadership because sustainable change ultimately depends on political decisions rather than scientific evidence alone.

    The debate, however, should not simply centre on whether scientists ought to enter politics. That is neither feasible nor necessary for everyone. A more important question is whether the global health workforce should systematically develop political literacy and political intelligence as core professional competencies.

    The assumption that evidence naturally informs policy has never accurately reflected reality. Policy decisions emerge from competing interests, institutional constraints, electoral considerations, financial incentives, historical relationships, and negotiations among multiple actors. Scientific evidence is essential, but it rarely speaks for itself.

    Equally important, influence rarely follows formal organisational hierarchies. Some of the most influential individuals in health policy occupy positions outside government ministries. Political advisers, parliamentary committees, professional associations, civil society organisations, philanthropic foundations, private sector leaders, journalists, and informal networks frequently shape policy decisions as much as — and sometimes more than — official decision makers.

    Effective health diplomacy therefore begins long before negotiations start. It begins with political intelligence: understanding who influences decisions, mapping relationships, recognising competing incentives, anticipating political windows of opportunity, and appreciating institutional realities. Stakeholder analysis should not be viewed as an administrative exercise but as an essential diplomatic competency.

    Political scientists remain surprisingly peripheral to a field whose greatest implementation challenges are fundamentally political. Economists, behavioural scientists, governance experts, historians, communication specialists, and diplomacy practitioners similarly remain underrepresented in many health policy discussions. Yet successful health reform increasingly depends upon understanding institutions, incentives, governance, public trust, negotiation, and political behaviour alongside biomedical science. Global health must therefore become genuinely multidisciplinary—not only in rhetoric but also in practice.

    Another important transition is equally overdue.

    For more than two decades, the global health community has become exceptionally good at diagnosing problems. Reports continue to document financing gaps, workforce shortages, implementation failures, inequitable partnerships, and governance weaknesses. These analyses have been invaluable.

    However, the next generation of global health leadership should spend less time describing familiar problems and more time systematically testing solutions.

    The critical question is no longer simply “What is wrong?”

    It is “How do we implement change under complex political conditions?”

    This requires closer integration between health politics, health diplomacy, implementation science, strategic foresight, and adaptive governance. Countries need evidence not only on what works, but on how reforms are financed, how institutions sustain change, how partnerships evolve, and how political commitment can survive electoral transitions and economic shocks.

    Health diplomacy itself must evolve accordingly.

    Rather than being understood solely as the art of negotiation, it should increasingly become the practice of creating political, institutional, and financial conditions that enable implementation, experimentation, learning, and continuous adaptation. Diplomacy should help countries collaborate not simply around agreements but around implementation. It should facilitate collective learning, strengthen trust, encourage innovation, and create the political space for responsible experimentation.

    Global health does not simply need better diplomacy.

    It needs a fit-for-purpose Health Politics and Diplomacy Agenda—one that recognises that science, politics, governance, diplomacy, and implementation are not competing domains but mutually reinforcing pillars of better health.

    The question is no longer whether health diplomacy has been relevant. The evidence suggests that it has. Although no universally accepted definition exists, health diplomacy has become an influential field that has strengthened international cooperation, brokered partnerships, mobilised resources, and helped negotiate collective action on some of the world’s most pressing health challenges. Its achievements are substantial and should not be understated. Yet past success does not necessarily guarantee future relevance. The more pressing question is whether our current understanding and practice of health diplomacy—and our relatively limited investment in health politics—remain fit for purpose in a global health landscape that has changed more rapidly than the competencies we teach, the institutions we have built, and the conceptual paradigms that continue to guide the field.

    If the twenty-first century has taught us anything, it is that good science alone is not enough. Lasting health gains require institutions capable of navigating politics with integrity, diplomacy with purpose, and leadership with courage.

    “A paradigm does not become obsolete because it failed. It becomes obsolete because the world changed while it stood still. A fit-for-purpose paradigm is one that continually evolves alongside the realities it seeks to influence. The challenge before global health is therefore not simply to improve health diplomacy, but to rethink how science, politics, diplomacy, and implementation interact in an increasingly complex and contested global landscape”

    About the Author

    He is an implementation research scientist, empirical bioethicist, and global health strategist. His work sits at the intersection of health politics and diplomacy, implementation research, science communication, meaningful decolonization of global health, health equity, and strategic partnerships. He is committed to strengthening the translation of evidence into policy and practice while advancing more equitable, locally led, and sustainable approaches to global health.

    Resources

    Kelly L. Characteristics of global health diplomacy. K4D Helpdesk Report. Brighton: Institute of Development Studies; 2021. Available from: https://www.gov.uk/research-for-development-outputs/characteristics-of-global-health-diplomacy

    Global Health Diplomacy Programme, Stockholm: Global Health Diplomacy Programme; [cited 2026 Jul 19]. Available from: https://globalhealthdiplomacy.se/programs

    Maidah, Alkhaldi M, AlKhaldi M, et al. Global health diplomacy in chronic humanitarian contexts like Palestine: a persistent blind spot and an underused approach. BMJ Glob Health. 2025;10(4):e018308. Available from: https://gh.bmj.com/content/10/4/e018308

    Ruckert A, Labonté R, Lencucha R, Runnels V, Gagnon M. Global health diplomacy: A critical review of the literature. Soc Sci Med. 2016;155:61–72. doi:10.1016/j.socscimed.2016.03.004. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0277953616301046

  • Reflections on the 2026 High-Level Political Forum on Sustainable Development

    Reflections on the 2026 High-Level Political Forum on Sustainable Development

    The 2026 High-Level Political Forum (HLPF) on Sustainable Development, the United Nations’ central venue for the follow up and review of the 2030 Agenda for Sustainable Development and its Sustainable Development Goals (SDGs), took place in New York from July 7- July 15, 2026. This forum convened delegates, heads of state, major groups, and other stakeholders to discuss the status of SDGs, Member States and institutions accountable, while outlining areas for further action and multi-stakeholder cooperation in the forthcoming years.  

    The Alliance briefly summarizes where progress on SDG 3: Good Health and Wellbeing stood at the time of the Forum, alongside the other SDGs under review. While SDG 3 was not a priority for review this year’s HLPF, policymakers, CSOs, and other stakeholders must continue to center health in all diplomatic engagements. Health considerations intersect with each development priority, and actions on the sustainable development agenda must be coordinated across SDGs. 

    SDG 3: Good Health and Well-Being

    SDG 3 on Good Health and Well-Being, central to the work of the Alliance, is of primary relevance. Progress on SDG 3 varies across each target. As of 2023, 133 countries have successfully met the SDG target on reducing the under-five mortality rate to 25 or fewer deaths per 1,000 live births. Global AIDS-related deaths have been reduced by over 50% since 2010, and concurrently, by the end of 2024, 54 countries had successfully eliminated at least one neglected tropical disease.  

    At the same time, progress has not been linear. Childhood vaccination rates have fallen and have not fully recovered from the disruption of the COVID-19 pandemic, and tuberculosis and malaria case counts have risen relative to pre-pandemic levels. Progress on Universal Health Coverage, which expanded rapidly between 2000 and 2015, has since slowed considerably and access remains largely unequal, especially within low-income countries where the gap between the covered and the uncovered is widest.

    In 2019, thirteen multilateral health, development, and humanitarian agencies launched the Global Action Plan for Healthy Lives and Well-being for All (SDG3 GAP) to help countries accelerate progress on health-related SDG. However, the initiative was discontinued in 2025 after an evaluation found that the GAP framework had not been delivered as intended and could not be sustained. The dissolution of this initiative raises an open question: who takes on multilateral coordination for health when the mechanism itself has been dissolved, and through what process is a successor arrangement? The review of SDG 17 at the HLPF offered a specific venue to raise this question specifically. These concerns can also be brought forward in future multilateral forums like those forthcoming under the UN80 process.

    SDGs Under Review

    This year’s HLPF theme was on “Transformative, equitable, innovative and coordinated actions for the 2030 Agenda and its SDGs for a sustainable future for all,” with a formal review of SDG 6 (Clean Water and Sanitation), SDG 7 (Affordable and Clean Energy), SDG 9 (Industry, Innovation, and Infrastructure), SDG 11 (Sustainable Cities and Communities), and SDG 17 (Partnerships for the Goals), which is reviewed every year as the SDG underpinning all the others.  

    Each of the SDGs are interconnected; progress in one SDG can drive progress in another as well. Any diplomatic solution must address and acknowledge the cross-cutting nature of the SDGs and leverage health diplomacy as a tool to drive developmental progress. While SDG 3 was not on the formal review agenda in 2026 (having been reviewed during the 2025 HLPF), health must be central to the conversation. There is an opportunity for health to be integrated within these conversations through development interlinkages. 

    • SDG 6 and health: The SDG 6 review must frame water and sanitation investment as a fundamental health investment, not solely an environmental or infrastructural solution. 
    • SDG 7 and health: The SDG 7 review must explore how energy standards can be integrated into national health plans.  
    • SDG 9 and health: Investments in infrastructure directly strengthen national preparedness for future health emergencies and must be considered. 
    • SDG 11 and health: Sustainable, resilient cities directly shape the non-communicable disease and injury burden that SDG 3 targets.  

    Available evidence and reporting indicated that international progress across all the SDGs remains inadequate, with only about a third of targets on track and almost a fifth of targets having regressed to below 2015 levels. With four years remaining until the 2030 deadline, the need to address SDGs through an intersectional and systems-level approach has become increasingly imperative. 

    Reflections from the Alliance

    The Health Diplomacy Alliance offers the following three reflections: 

    • Stakeholders had an opportunity to center health in this year’s review. Since SDG 3 itself was not under formal review in 2026, stakeholders at HLPF could have actively framed health as a contingent to the progress of SDG 6, 7, 9, 11, and 17, and highlight the interdependent nature of the SDGs. 
    • With the SDG 3 GAP closed, the SDG 17 partnerships review offered a venue to advocate for a clearly mandated, adequately resourced coordination structure among multilateral health actors that builds from the GAP’s shortcomings. 
    • Health targets as UHC and immunization remain instruments of health diplomacy. Progress on all SDGs is directly tied to political willingness and financing priorities. The achievements of the past decade—including reductions in child mortality and the elimination of several diseases— demonstrated that strong diplomatic and financial commitment can save lives, drive change, and accelerate progress towards achieving the 2030 Agenda for Sustainable Development 

    The High-Level Political Forum provided a critical window to integrate health targets into broader conversations around water, energy, and sustainable urban planning. This integrated approach prevents health from being treated as an isolated, “siloed” issue, recognizing that achieving sustainable, resilient global health outcomes depends on coordinated, multilateral action that embeds health considerations within development. 

    Organizer

  • Health Diplomacy House (HDH)

    Health Diplomacy House (HDH)

    Overview

    On 21 May 2026, we convened the Health Diplomacy House alongside the 79th World Health Assembly in Geneva. Designed as an informal, cross-sector platform for dialogue, the House brought together policymakers, diplomats, researchers, civil society, youth leaders, international organizations, philanthropic actors, and the private sector to address some of the most pressing challenges facing global health today.

    Across 16 sessions, participants explored practical policy discussions that could bring factual solutions on global health governance, sustainable financing, climate and health, antimicrobial resistance (AMR), One Health, women’s leadership, and health system resilience. Rather than focusing solely on discussion, the House emphasized collaboration, knowledge exchange, and actionable ideas that can support future policy development.

    @Health Diplomacy Alliance

    At a time of increasing geopolitical uncertainty, financial pressures, and evolving global health priorities, the Health Diplomacy House created space for conversations that are often difficult to hold within formal diplomatic settings.

    By bringing together diverse perspectives across sectors and generations, the initiative encouraged honest dialogue, strengthened partnerships, and connected policy discussions with practical implementation challenges.

    The event reinforced the importance of health diplomacy as a tool for building cooperation around shared global health priorities.

    Key Themes

    @Health Diplomacy Alliance

    Rather than organizing discussions around a single issue, the programme reflected the interconnected nature of today’s health challenges. Major themes included:

    • Reforming global health governance and strengthening multilateral cooperation
    • Innovative approaches to sustainable health financing
    • Climate change and its growing impact on human health
    • One Health and antimicrobial resistance
    • Health system resilience in fragile and conflict-affected settings
    • Women’s leadership in global health diplomacy
    • Ethical health workforce mobility
    • The role of journalism, accountability, and transparency in global health

    Major Outcomes

    Several common messages emerged throughout the day:

    • Strengthening Global Health Reform Processes: Discussions reaffirmed that reform of the international system for health is no longer a question of whether but how. Many efforts are now running in parallel across different institutions and regions, rather than converging around any single process, with several expected to produce concrete proposals by late 2026 and recommendations feeding into the 80th World Health Assembly in 2027. Security and peace, and antimicrobial resistance, were repeatedly named among the most pressing issues these processes will be judged against.
    • Advancing Transparency and Trust in Global Health: A deep-rooted trust deficit was named as a central obstacle to reform. Participants called for greater transparency, clearer communication of ongoing processes, and honest acknowledgment of the political economy that has undermined past reform efforts, arguing that legitimacy depends as much on how reform is communicated as on what it ultimately delivers.
    @Health Diplomacy Alliance
    • Elevating Women’s Leadership in Health Diplomacy: The exchange produced a clear call for parity not only in numbers but also in decision-making spaces, identifying specific structural barriers and concrete pathways toward more gender-responsive health diplomacy.
    • Climate Obligations and Economics in Health Governance: Discussion of the International Court of Justice’s advisory opinion on climate change examined how its binding state obligations could be integrated into ongoing global health law and governance processes, including the World Health Assembly’s own engagement with climate and health. This was paired with health-economics work quantifying the cost side of that argument, including published analysis of the social cost of carbon, value of a statistical life, and macroeconomic modeling of climate action and inaction in health terms, treating the economic case and the legal case as two halves of the same argument for embedding climate squarely within health governance.
    • Debt and Health Financing: A deep dive examination on how sovereign debt restructuring can be linked directly to domestic health investment, positioning debt relief as a health financing tool in its own right rather than a separate fiscal question, is particularly relevant for states facing both debt distress and financing gaps in their health systems.
    • The Gap Between Commitment and Implementation on AMR: Consultation underscored that political commitments only matter once they shape procurement, surveillance, workforce planning, and prescribing practice. Participants pointed to persistent gaps in financing, multisectoral coordination, and evidence systems as the real test of whether the current AMR agenda produces change rather than further declarations.
    • Traditional Medicine, Biodiversity, and Environmental Health: Debate on traditional medicine and biodiversity, and on the health impacts of plastics extended the reform conversation beyond financing and governance to the underlying environmental and cultural systems health depends on, reinforcing the argument that reform needs to be judged against a wider set of pressing issues than institutional architecture alone.
    @Health Diplomacy Alliance
  • International Day of Women in Diplomacy 2026

    International Day of Women in Diplomacy 2026

    On the International Day of Women in Diplomacy, we celebrate the women whose leadership, expertise, and commitment continue to shape global cooperation, peace, and health.

    Women have always played a vital role in diplomacy, yet representation gaps remain. As of 2024, women accounted for just 21% of Permanent Representatives to the United Nations (Source: UN), and between 1992 and 2019, women made up only 13% of negotiators in major peace processes worldwide (Source: Council on Foreign Relations (CFR)). Despite these challenges, women diplomats continue to drive change, build bridges, and strengthen multilateral action.

    We recognize that more inclusive diplomacy leads to stronger institutions, better decisions, and more effective responses to global challenges. As we mark this day, we celebrate the women whose voices, leadership, and vision are helping shape the future of global health and international cooperation.

    Today, we take the opportunity to feature the reflections from inspiring women in diplomacy whose words remind us of the power of representation, collaboration, and leadership:

    Do you see women becoming more vocal and more present in the negotiations and current major discussions in global health ?

    What has brought you this far in international relations ?

  • AMR – G7 Summit, Evian – June 2026

    AMR – G7 Summit, Evian – June 2026

    Antimicrobial resistance (AMR) has emerged over the past decade as an accelerating challenge to health, development and security agendas. While often framed as a technical matter, AMR is in fact a structural phenomenon directly shaped by how societies organize their health systems, food production, environmental regulation, and international cooperation. In this respect, it resembles other crossborder challenges that have forced policymakers to rethink traditional distinctions between domestic and foreign policy, with consequences that are particularly pronounced in low and middle-income countries where health systems are already under strain. 

    The G7 Summit in Evian comes at a moment when this structural dimension of AMR is increasingly evident. The adoption of a political declaration on AMR at the United Nations General Assembly on 2024 and the recent One Health Summit during April in Lyon have both acknowledged that the continued erosion of antimicrobial effectiveness threatens to reverse gains in life expectancy, productivity and poverty reduction. However, as with many global health issues, there remains a gap between the scale of the commitments made and the pace at which they are translated into implementation on the ground.  

    The Health Diplomacy Alliance views health as both an outcome of, and a contributor to, broader patterns of stability and cooperation. AMR illustrates this dual role. On the one hand, rising resistance directly affects the ability of health systems to deliver, thus eroding public trust when health services can no longer provide effective treatment for common infections. On the other hand, the way governments, international organizations and private actors respond to AMR signals the reliability of global cooperation and the value placed on prevention. 

    Recent discussions at Lyon One Health summit have reinforced the understanding that AMR cannot be addressed in isolation from its wider One Health context. Therefore, in light of these developments, this commentary identifies areas where sustained G7 engagement, coordinated with other partners, could have substantial impact if it is sustained over time.  

    AMR must be recognized as a strategic global risk

    There is a case for G7 governments to treat AMR as a core strategic risk, by integrating it into national security strategies, development cooperation frameworks and climate policies rather than confining it to health ministries alone. Doing so would recognize that resistance undermines not only clinical outcomes, but also economic resilience, trade, and the functioning of health systems in crisis settings. 

    Political commitments and implementation

    G7 countries are well placed to support and close the implementation and financing gap that continues to limit the effectiveness of many national AMR action plans. This does not imply substituting for domestic responsibility, but highlighting on existing mechanisms, such as development banks, the Pandemic Fund and other global health instruments to support investments in primary health care, laboratories, surveillance and workforce development that are essential for both AMR and broader health security. A shared objective, for example, that by 2030 a majority of countries have fully costed, and partially funded AMR plans aligned with One Health principles, would offer a useful point for such efforts and enable more systematic monitoring of progress over time. 

    Closing financing gaps – for national AMR Plans

    The G7 is well positioned to lend political and financial support to the development of integrated One Health governance for AMR. Many national AMR action plans exist on paper, but too few are fully costed, funded and operationalized. The G7, could support predictable financing for laboratories, surveillance, primary care, workforce development and infection prevention, especially in low and middle-income countries where the burden of resistance is compounded by broader weaknesses in health systems.  

    Building interoperable One Health surveillance, diagnostics and data systems

    Attention should be given to surveillance and data. The One Health Data Convergence initiatives launched in Lyon specifically stress the need for systems that connect human, animal, and environmental information in usable ways. Such support should be designed in a way that strengthens national institutions rather than creating parallel structures and could include investments in the analytical and policy capacities needed to interpret and act on the data generated Support for diagnostics capacity and analytical expertise would make it possible to detect resistance earlier and to respond more effectively. 

    Ensure AMR policies prioritize civil‑society engagement

    Any meaningful response to AMR will depend on structured engagement with civil society organizations and other community actors who can connect scientific evidence with practice. CSOs are already supporting AMR efforts in areas such as awarenessraising, behavior change, surveillance, and monitoring of policy commitments, but their potential contributions to implementation and knowledge generation are still underutilized. Involving CSOs, youth groups and local authorities in the codesign of interventions, communitybased research and implementation science can help ensure that AMR policies are grounded in realworld experience and that scientific guidance is adapted to local contexts.  

    The AMR issue is important because it exposes the limits of fragmented responses and the need for a more integrated approach to health, development, and diplomacy.  

    Closer alignment between political commitments with financing, governance, and implementation would strengthen the international response to AMR and reinforce the practical relevance of One Health approach.  The Health Diplomacy Alliance will continue to follow this development with interest and reflect it on its Check the Box Initiative.